EDWARD PARISI: Open Payments
NPI 1487664215 · FAIRLAWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,478 in 198 payments from 30 companies in 2025. Trend: 2023 $2,863 · 2024 $3,229 · 2025 $3,478
Food & beverage: $3,478
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $532 |
| Corcept Therapeutics | 12 | $344 |
| Lilly USA, LLC | 21 | $288 |
| Amgen Inc. | 16 | $255 |
| Novo Nordisk Inc | 17 | $243 |
| AstraZeneca Pharmaceuticals LP | 10 | $241 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 16 | $197 |
| Otsuka America Pharmaceutical, Inc. | 10 | $148 |
| Optinose US, Inc. | 7 | $140 |
| Daiichi Sankyo Inc. | 5 | $101 |
Products named: Korlym, VRAYLAR, JARDIANCE, MOUNJARO, REXULTI, Ozempic, Xhance, REPATHA.
Industry payments across OH — which companies pay providers there.
